Ontvang nu dagelijks onze kooptips!
word abonnee
sluiten ✕
Terug naar discussie overzicht
en weer de enige rooie rakker
HS2 timescale is unrealistic says spending watchdog Search News Archive Related News Railway school on course to open next year Cross-channel contracting JV picks cross-channel consultants for HS2 Auditors roast Green Deal failures HS2 construction purchasers hit the road again HS2 top brass agree quarterly union meetings The National Audit Office – the government spending watchdog – says that the construction timetable for the £56bn High Speed 2 rail project is 'unrealistic'. In its second report on the HS2 project1, the NAO said that the London-Birmingham first phase was unlikely to be completed by 2026 as planned. However, HS2 Ltd, the government company tasked with delivering the project for the Department for Transportr, said it remained confident the project would remain both within budget and on schedule. NAO head Amyas Morse said: “HS2 is a large, complex and ambitious programme which is facing cost and time pressures. The unrealistic timetable set for HS2 Ltd by the Department means they are not as ready to deliver as they hoped to be at this point. The Department now needs to get the project working to a timescale that is achievable.” The NAO report says that phase 1 is currently forecast to cost £27,384 million, exceeding available funding by £204 million. There is less contingency to deliver phase 1 than the Department for Transport (DfT) and HS2 Ltd were aiming for at this stage, and this forecast assumes that planned efficiencies totalling £1.47 billion will be realised. Cost estimates for phase 2 are at a much earlier stage of development and some elements are unfunded. At the 2015 Spending Review, the estimated cost of phase 2 exceeded available funding by £7 billion. Since then work by the DfT, HS2 Ltd and a review commissioned by the Cabinet Office has identified potential savings of £9 billion, £2 billion of which have been secured. The NAO says that there is a risk that the combined impact of cost and schedule pressures result in reduced programme scope, and lower the benefit cost ratio. The benefit cost ratio for phase 1 assumes that the programme is delivered well within its available funding. If the outturn is closer to, or exceeds, available funding, which, given current cost and schedule pressures, is a possibility, then the benefit cost ratio, including wider economic benefits, would fall from 1.7 to around 1.5. If the programme is delayed, then benefits would be deferred. The government has asked HS2 Ltd to explore options for reducing the programme scope in ways that do not have a significant impact on programme benefits. According to today’s report, “effective integration of HS2 with the wider UK rail system is challenging and poses risks to value for money”. The NAO says that the DfT needs to address how HS2 services will complement or compete with other rail services, and how HS2 will interact with proposed improvements in the north. “Failure to fully understand these interactions and make decisions in the right sequence will make delivering the programme more challenging,” it says. “It could also mean decisions are made now which reduce benefits or increase costs across the network in future.” In response, HS2 said that the NAO report confirmed that “whilst many challenges remain, the project is on track both to deliver its strategic scope and to do so on budget”. HS2 said: “At each stage the combination of value engineering, plus the lessons we have taken from international best practice and innovation is helping HS2 both to drive down cost and increase our confidence in our ability to deliver, and that is a process that will continue. “That increasing confidence allowed the project earlier this month to invite the industry to bid for around £11bn worth of contracts for Phase One. “As the report acknowledges, each of those contracts also contain specific incentives for partners to work with HS2 to keep identifying further ways in which costs can be saved and efficiencies realised, without compromising the strategic scope and objectives of the project. “Those lessons from Phase One are already being applied to, and will continue to be applied to Phase Two as well where the scope for efficiencies is even greater precisely because it is at an earlier design stage. Responding to the NAO report, HS2 chief executive Simon Kirby said: “The role of the NAO is to challenge projects such as HS2 and through that challenge improve the way they deliver for the taxpayer. This report does this and we accept that challenge. “It also, however, recognises the real progress we have made in taking the concept of HS2 and moving it nearer reality. “As the report says, HS2 remains a highly ambitious project, but as it also demonstrates there are real and substantial grounds why the public, government and parliament should have increased confidence in our ability to deliver the project. Our job is to keep earning that confidence going forward.”
3,15 was laag ...vorige week...
Eurowin schreef op 28 juni 2016 10:52 :
3,15 was laag ...vorige week...
Ik ga er vanuit dat BAM ook klappen krijgt op langere termijn door Brexit. de kat.
Willem 007 schreef op 28 juni 2016 10:59 :
[...]
Ik ga er vanuit dat BAM ook klappen krijgt op langere termijn door Brexit.
Nog meer ? dan is het gelijk pleepapier. Ja, die Engelsen toch he. Die hebben wat veroorzaakt zo links en rechts. En over 6 maanden zal blijken of dit koopkansen waren of dat er een ledenstop nodig is bij voedsel en kledingbanken en er een bordje "bezet" hangt bij elke parkbank die je tegenkomt.
pardon schreef op 6 juni 2016 08:57 :
Ik heb er 5000 ingelegd op 4,15 ik wil ze wel hebben.
5000x (4,15-3,19)=4800 verlies.. Of was deze post stemmingmakerij;)
Trap het maar lager en lager
Rotjeknor schreef op 28 juni 2016 11:26 :
Trap het maar lager en lager
Komt ook van de negatieve adviezen van die Amerikaanse oplichters-banken. Die komen nu met dubieuze lagere adviezen voor veel Nederlandse fondsen. Stelletje tuig , die ruiken bloed!
manuss schreef op 28 juni 2016 11:31 :
[...]Komt ook van de negatieve adviezen van die Amerikaanse oplichters-banken. Die komen nu met dubieuze lagere adviezen voor veel Nederlandse fondsen. Stelletje tuig , die ruiken bloed!
is niet zo moeilijk om bloed te ruiken, maar ze verstevigen de onrust wel
€d_Modus Vivendi schreef op 28 juni 2016 11:33 :
[...]is niet zo moeilijk om bloed te ruiken, maar ze verstevigen de onrust wel
Volgens mij doen ze dat daar met opzet, zullen er wel belang bij hebben.
SINTRA, Portugal—European Central Bank President Mario Draghi urged major central banks to better coordinate their policies to tackle the shared problem of ultralow inflation, warning that competitive currency devaluations are a "lose-lose" for the global economy. Speaking at a major ECB conference in Portugal, Mr. Draghi said divergent monetary policies among major central banks can create uncertainty about their policy intentions, "which in turn leads to higher exchange-rate volatility and risk premia." "In a globalized world, the global policy mix matters—and will likely matter more as our economies become more integrated," Mr. Draghi said. "So we have to think not just about whether our domestic monetary policies are appropriate, but whether they are properly aligned across jurisdictions."
Voor de beurzen is het te hopen , dat er een duidelijk verhaal komt uit de vergadering van die zgn. geld-volgevreten regeringsleiders.
Er wordst weer behoorlijk geprovoceerd met de koers. Van 3,31 hoog naar 3,16 laag. Stoplosses triggeren? Onrust zaaien? Om daarna (wellicht vanaf nu) een rebound te maken? Pogingen waren er vanochtend, maar werden weggedumot. Van 3,165 naar 3,21 in één lijn lijkt nu toch even ergens op.. Come on guys! This company ain't that bad..
manuss schreef op 28 juni 2016 11:43 :
Voor de beurzen is het te hopen , dat er een duidelijk verhaal komt uit de vergadering van die zgn. geld-volgevreten regeringsleiders.
. Dit gaat toch wel ver of niet, volkomen door het putje en waarom dan wel? Er ontbreekt echt onderbouwing. BAM mag weleens wat naar buiten brengen over hoe ze er zelf in staat en hoe de vlag erbij hangt. Ik hoop ook dat er wat fatsoenlijks uit die vergadering komt. Maar de Engelsen zijn zelf zo stom geweest dit in gang te zetten!
Crusader schreef op 28 juni 2016 11:49 :
Er wordst weer behoorlijk geprovoceerd met de koers.
Van 3,31 hoog naar 3,16 laag. Stoplosses triggeren? Onrust zaaien?
Om daarna (wellicht vanaf nu) een rebound te maken?
Pogingen waren er vanochtend, maar werden weggedumot.
Van 3,165 naar 3,21 in één lijn lijkt nu toch even ergens op..
Come on guys! This company ain't that bad..
zitten alleen een beetje in het verkeerde land
€d_Modus Vivendi schreef op 28 juni 2016 11:37 :
SINTRA, Portugal—European Central Bank President Mario Draghi urged major central banks to better coordinate their policies to tackle the shared problem of ultralow inflation, warning that competitive currency devaluations are a "lose-lose" for the global economy.
Speaking at a major ECB conference in Portugal, Mr. Draghi said divergent monetary policies among major central banks can create uncertainty about their policy intentions, "which in turn leads to higher exchange-rate volatility and risk premia."
"In a globalized world, the global policy mix matters—and will likely matter more as our economies become more integrated," Mr. Draghi said.
"So we have to think not just about whether our domestic monetary policies are appropriate, but whether they are properly aligned across jurisdictions."
Toe maar: Sintra... Niet bepaald de meest slechte plek op deze aardkloot... Ze praatten, ze vraten, ze namen een glas, deden een plas, en alles bleef, zoals het was...
Crusader schreef op 28 juni 2016 11:49 :
Er wordst weer behoorlijk geprovoceerd met de koers.
Van 3,31 hoog naar 3,16 laag. Stoplosses triggeren? Onrust zaaien?
Om daarna (wellicht vanaf nu) een rebound te maken?
Pogingen waren er vanochtend, maar werden weggedumot.
Van 3,165 naar 3,21 in één lijn lijkt nu toch even ergens op..
Come on guys! This company ain't that bad..
Ja precies. Helemaal van de gekke dit. Je praat hooguit over 10% negatief valutaeffect over de winst uit. 30% omzet van het totaal. Dat lijkt me toch wel allang ingeprijst. Bovendien zijn ze er nog lang niet uit. Het is allemaal stemmingmakerij. Bah bah en nog eens BAH!!
wonderlijk dat de banken met de grootste risico's bij brexit vandaag weer ruim presteren Alsof er ook maar iets veranderd is.
Aantal posts per pagina:
20
50
100
Direct naar Forum
-- Selecteer een forum --
Koffiekamer
Belastingzaken
Beleggingsfondsen
Beursspel
BioPharma
Daytraders
Garantieproducten
Opties
Technische Analyse
Technische Analyse Software
Vastgoed
Warrants
10 van Tak
4Energy Invest
Aalberts
AB InBev
Abionyx Pharma
Ablynx
ABN AMRO
ABO-Group
Acacia Pharma
Accell Group
Accentis
Accsys Technologies
ACCSYS TECHNOLOGIES PLC
Ackermans & van Haaren
ADMA Biologics
Adomos
AdUX
Adyen
Aedifica
Aegon
AFC Ajax
Affimed NV
ageas
Agfa-Gevaert
Ahold
Air France - KLM
Airspray
Akka Technologies
AkzoNobel
Alfen
Allfunds Group
Allfunds Group
Almunda Professionals (vh Novisource)
Alpha Pro Tech
Alphabet Inc.
Altice
Alumexx ((Voorheen Phelix (voorheen Inverko))
AM
Amarin Corporation
Amerikaanse aandelen
AMG
AMS
Amsterdam Commodities
AMT Holding
Anavex Life Sciences Corp
Antonov
Aperam
Apollo Alternative Assets
Apple
Arcadis
Arcelor Mittal
Archos
Arcona Property Fund
arGEN-X
Aroundtown SA
Arrowhead Research
Ascencio
ASIT biotech
ASMI
ASML
ASR Nederland
ATAI Life Sciences
Atenor Group
Athlon Group
Atrium European Real Estate
Auplata
Avantium
Axsome Therapeutics
Azelis Group
Azerion
B&S Group
Baan
Ballast Nedam
BALTA GROUP N.V.
BAM Groep
Banco de Sabadell
Banimmo A
Barco
Barrick Gold
BASF SE
Basic-Fit
Basilix
Batenburg Beheer
BE Semiconductor
Beaulieulaan
Befimmo
Bekaert
Belgische aandelen
Beluga
Beter Bed
Bever
Binck
Biocartis
Biophytis
Biosynex
Biotalys
Bitcoin en andere cryptocurrencies
bluebird bio
Blydenstijn-Willink
BMW
BNP Paribas S.A.
Boeing Company
Bols (Lucas Bols N.V.)
Bone Therapeutics
Borr Drilling
Boskalis
BP PLC
bpost
Brand Funding
Brederode
Brill
Bristol-Myers Squibb
Brunel
C/Tac
Campine
Canadese aandelen
Care Property Invest
Carmila
Carrefour
Cate, ten
CECONOMY
Celyad
CFD's
CFE
CGG
Chinese aandelen
Cibox Interactive
Citygroup
Claranova
CM.com
Co.Br.Ha.
Coca-Cola European Partners
Cofinimmo
Cognosec
Colruyt
Commerzbank
Compagnie des Alpes
Compagnie du Bois Sauvage
Connect Group
Continental AG
Corbion
Core Labs
Corporate Express
Corus
Crescent (voorheen Option)
Crown van Gelder
Crucell
CTP
Curetis
CV-meter
Cyber Security 1 AB
Cybergun
D'Ieteren
D.E Master Blenders 1753
Deceuninck
Delta Lloyd
DEME
Deutsche Cannabis
DEUTSCHE POST AG
Dexia
DGB Group
DIA
Diegem Kennedy
Distri-Land Certificate
DNC
Dockwise
DPA Flex Group
Draka Holding
DSC2
DSM
Duitse aandelen
Dutch Star Companies ONE
Duurzaam Beleggen
DVRG
Ease2pay
Ebusco
Eckert-Ziegler
Econocom Group
Econosto
Edelmetalen
Ekopak
Elastic N.V.
Elia
Endemol
Energie
Energiekontor
Engie
Envipco
Erasmus Beursspel
Eriks
Esperite (voorheen Cryo Save)
EUR/USD
Eurobio
Eurocastle
Eurocommercial Properties
Euronav
Euronext
Euronext
Euronext.liffe Optiecompetitie
Europcar Mobility Group
Europlasma
EVC
EVS Broadcast Equipment
Exact
Exmar
Exor
Facebook
Fagron
Fastned
Fingerprint Cards AB
First Solar Inc
FlatexDeGiro
Floridienne
Flow Traders
Fluxys Belgium D
FNG (voorheen DICO International)
Fondsmanager Gezocht
ForFarmers
Fountain
Frans Maas
Franse aandelen
FuelCell Energy
Fugro
Futures
FX, Forex, foreign exchange market, valutamarkt
Galapagos
Gamma
Gaussin
GBL
Gemalto
General Electric
Genfit
Genmab
GeoJunxion
Getronics
Gilead Sciences
Gimv
Global Graphics
Goud
GrandVision
Great Panther Mining
Greenyard
Grolsch
Grondstoffen
Grontmij
Guru
Hagemeyer
HAL
Hamon Groep
Hedge funds: Haaien of helden?
Heijmans
Heineken
Hello Fresh
HES Beheer
Hitt
Holland Colours
Homburg Invest
Home Invest Belgium
Hoop Effektenbank, v.d.
Hunter Douglas
Hydratec Industries (v/h Nyloplast)
HyGear (NPEX effectenbeurs)
HYLORIS
Hypotheken
IBA
ICT Automatisering
Iep Invest (voorheen Punch International)
Ierse aandelen
IEX Group
IEX.nl Sparen
IMCD
Immo Moury
Immobel
Imtech
ING Groep
Innoconcepts
InPost
Insmed Incorporated (INSM)
IntegraGen
Intel
Intertrust
Intervest Offices & Warehouses
Intrasense
InVivo Therapeutics Holdings Corp (NVIV)
Isotis
JDE PEET'S
Jensen-Group
Jetix Europe
Johnson & Johnson
Just Eat Takeaway
Kardan
Kas Bank
KBC Ancora
KBC Groep
Kendrion
Keyware Technologies
Kiadis Pharma
Kinepolis Group
KKO International
Klépierre
KPN
KPNQwest
KUKA AG
La Jolla Pharmaceutical
Lavide Holding (voorheen Qurius)
LBC
LBI International
Leasinvest
Logica
Lotus Bakeries
Macintosh Retail Group
Majorel
Marel
Mastrad
Materialise NV
McGregor
MDxHealth
Mediq
Melexis
Merus Labs International
Merus NV
Microsoft
Miko
Mithra Pharmaceuticals
Montea
Moolen, van der
Mopoli
Morefield Group
Mota-Engil Africa
MotorK
Moury Construct
MTY Holdings (voorheen Alanheri)
Nationale Bank van België
Nationale Nederlanden
NBZ
Nedap
Nedfield
Nedschroef
Nedsense Enterpr
Nel ASA
Neoen SA
Neopost
Neovacs
NEPI Rockcastle
Netflix
New Sources Energy
Neways Electronics
NewTree
NexTech AR Solutions
NIBC
Nieuwe Steen Investments
Nintendo
Nokia
Nokia OYJ
Nokia Oyj
Novacyt
NOVO-NORDISK AS
NPEX
NR21
Numico
Nutreco
Nvidia
NWE Nederlandse AM Hypotheek Bank
NX Filtration
NXP Semiconductors NV
Nyrstar
Nyxoah
Océ
OCI
Octoplus
Oil States International
Onconova Therapeutics
Ontex
Onward Medical
Onxeo SA
OpenTV
OpGen
Opinies - Tilburg Trading Club
Opportunty Investment Management
Orange Belgium
Oranjewoud
Ordina Beheer
Oud ForFarmers
Oxurion (vh ThromboGenics)
P&O Nedlloyd
PAVmed
Payton Planar Magnetics
Perpetuals, Steepeners
Pershing Square Holdings Ltd
Personalized Nursing Services
Pfizer
Pharco
Pharming
Pharnext
Philips
Picanol
Pieris Pharmaceuticals
Plug Power
Politiek
Porceleyne Fles
Portugese aandelen
PostNL
Priority Telecom
Prologis Euro Prop
ProQR Therapeutics
PROSIEBENSAT.1 MEDIA SE
Prosus
Proximus
Qrf
Qualcomm
Quest For Growth
Rabobank Certificaat
Randstad
Range Beleggen
Recticel
Reed Elsevier
Reesink
Refresco Gerber
Reibel
Relief therapeutics
Renewi
Rente en valuta
Resilux
Retail Estates
RoodMicrotec
Roularta Media
Royal Bank Of Scotland
Royal Dutch Shell
RTL Group
RTL Group
S&P 500
Samas Groep
Sapec
SBM Offshore
Scandinavische (Noorse, Zweedse, Deense, Finse) aandelen
Schuitema
Seagull
Sequana Medical
Shurgard
Siemens Gamesa
Sif Holding
Signify
Simac
Sioen Industries
Sipef
Sligro Food Group
SMA Solar technology
Smartphoto Group
Smit Internationale
Snowworld
SNS Fundcoach Beleggingsfondsen Competitie
SNS Reaal
SNS Small & Midcap Competitie
Sofina
Softimat
Solocal Group
Solvac
Solvay
Sopheon
Spadel
Sparen voor later
Spectra7 Microsystems
Spotify
Spyker N.V.
Stellantis
Stellantis
Stern
Stork
Sucraf A en B
Sunrun
Super de Boer
SVK (Scheerders van Kerchove)
Syensqo
Systeem Trading
Taiwan Semiconductor Manufacturing Company (TSMC)
Technicolor
Tele Atlas
Telegraaf Media
Telenet Groep Holding
Tencent Holdings Ltd
Tesla Motors Inc.
Tessenderlo Group
Tetragon Financial Group
Teva Pharmaceutical Industries
Texaf
Theon International
TherapeuticsMD
Thunderbird Resorts
TIE
Tigenix
Tikkurila
TINC
TITAN CEMENT INTERNATIONAL
TKH Group
TMC
TNT Express
TomTom
Transocean
Trigano
Tubize
Turbo's
Twilio
UCB
Umicore
Unibail-Rodamco
Unifiedpost
Unilever
Unilever
uniQure
Unit 4 Agresso
Univar
Universal Music Group
USG People
Vallourec
Value8
Value8 Cum Pref
Van de Velde
Van Lanschot
Vastned
Vastned Retail Belgium
Vedior
VendexKBB
VEON
Vermogensbeheer
Versatel
VESTAS WIND SYSTEMS
VGP
Via Net.Works
Viohalco
Vivendi
Vivoryon Therapeutics
VNU
VolkerWessels
Volkswagen
Volta Finance
Vonovia
Vopak
Warehouses
Wave Life Sciences Ltd
Wavin
WDP
Wegener
Weibo Corp
Wereldhave
Wereldhave Belgium
Wessanen
What's Cooking
Wolters Kluwer
X-FAB
Xebec
Xeikon
Xior
Yatra Capital Limited
Zalando
Zenitel
Zénobe Gramme
Ziggo
Zilver - Silver World Spot (USD)